You are here: Home / Pharmacology / Research / Overview / Publications archive

Publications: 2002

On this page:

Book chapters

  1. Vaughan CW, Christie MJ (2002) Mechansims of Cannabinoid Analgesia. Journal of Physiology, 543, 531-540
Back to top

Refereed journal articles

  1. D'Arbe M, Einstein R and Lavidis NA (2002) Stressful animal housing conditions and their potential effect on sympathetic neurotransmission in mice. Am J Physiology. 282, R1422-R1428
  2. Black JL, Johnson PRA (2002) Factors controlling smooth muscle proliferation and airway remodelling. Current Opinion in Allergy & Immunology. 2:47-51
  3. Borgland SL, Connor M, Ryan RM, Ball* HJ, and Christie MJ (2002) Prostaglandin E2 inhibits calcium current in two subpopulations of acutely isolated mouse trigeminal sensory neurons Journal of Physiology (London), 539, 433-444
  4. Borger P, Black JL and Roth M (2002) Asthma and the CCAAT-enhancer binding proteins: a holistic view on airway inflammation and remodelling. Journal of Allergy and Clinical Immunology, 110, 841-846
  5. Burgess JK and McParland BE (2002) Analysis of gene expression, Methods in Enzymology, Vol.356
  6. *Chitturi S, *Abeygunasekera S, **Farrell GC, *Holmes-Walker J, *Hui J, *Fung C, *Karim R, *Lin R, *Samarasinghe D, Liddle C, *Weltman M and *George J. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology, 35, 373-379
  7. *Chitturi S, *Farrell G, *Frost L, *Kriketos A, *Lin R, Liddle C, *Samarasinghe D and George J (2002) Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? Hepatology, 36, 403-409
  8. *Chitturi S, *Weltman M, **Farrell GC, *McDonald D, Liddle C, *Samarasinghe D, *Lin R, *Abeygunasekera S and *George J (2002) HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology, 36, 142-149
  9. Daviskas E, Anderson SD, Eberl S, Chanl HK, Young IH and Seale JP (2002) Effects of terbutaline in combination with mannitol on mucociliary clearance, European Respiratory Journal, 20, 1423-1429
  10. Dean AJ, Bell J, Mascord DJ, Parker G & Christie MJ (2002). A randomised controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms. Journal of Affective Disorders (in press)
  11. **Dedov VN, **Tran VH, **Duke CC, Connor M, Christie MJ, **Mandadi S, *Roufougalis BD. (2002) Gingerols: a novel class of vanilloid receptor (VR1) agonists. British Journal of Pharmacology, 137, 793-798
  12. Dodds HM, Tobin PJ, Stewart CF, Cheshire P, Hanna S, Houghton P and Rivory LP (2002) The importance of tumor glucuronidase in the activation of irinotecan in a mouse zenograft model. The Journal of Pharmacology and Experimental Therapeutics, 303, 649-655
  13. **Farrell GC, Liddle C (2002) Forward: Drugs and the Liver Updated, 2002. Semin. Liver Dis. 22, 109-114
  14. **Farrell GC, Liddle C (Eds) (2002) Hepatotoxicity in the 21st Century. Semin. Liver Dis., 22, 109-206
  15. *Goodwin B, *Hodgson E, *D'Costa DJ, *Robertson GR, Liddle C. (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol., 62, 359-365
  16. *Hui JM, *George J, Liddle C, *Lin R, *Samarasinghe D, *Crewe E and *Farrell GC (2002) Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: Effects of response and emergence of drug resistance. American Journal of Gastroenterology, 97, 1003-1009
  17. *Hui JM, *Kench J, *Farrell GC, *Lin R, *Samarasinghe D, Liddle C, *Byth K and *George J (2002) Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection. Journal of Gastroenterology & Hepatology. 17, 873-881
  18. Johnston GAR (2002) Medicinal chemistry and molecular pharmacology of GABA-C receptors. Current Topics in Medicinal Chemistry, 2, 903-913
  19. Kassiou M, Bottlaender M, Loc'h C, Dolle F, Musachio JL, Coulon C, Ottavianni, M, Dannals RF, Maziere B. (2002) Pharmacological evaluation of a Br-76 analogue of epibatidine: A potent ligand for studying brain nicotinic acetylcholine receptors. Synapse 45, 95-104
  20. Kassiou M, Loc'h C, Bottlaender M, Mardon K, Ottavianni M, Coulon C, Katsifis A, Maziere B. (2002) (+)-[76Br]A-69024: A Non-benzazepine Radioligand for Studies of Dopamine D1 Receptors Using PET. Nucl. Med. Biol 29, 295-302
  21. Kassiou M, Loc'h C, Dolle F, Musachio JL, Dolci L, Crouzel C, Dannals RF, Maziere B. (2002) Preparation of a bromine-76 labelled analogue of epibatidine: A potent ligand for nicotinic acetylcholine receptor studies. Appl. Rad. Isotop. 57, 713-717
  22. *Lai KPL, *Tsang SWY, *Francis PT, *Keene J, *Hope T, *Esiri MM, Spence I and *Chen CPL (2002) Postmortem serotoninergic correlates of cognitive decline in Alzheimer's Disease. NeuroReport 13, 1175-1178
  23. Liddle C, *Goodwin B (2002) Regulation of Hepatic Drug Metabolism: Role of the Nuclear Receptors PXR and CAR. Semin Liver Dis. 22, 115-122
  24. Marinelli S, Vaughan CW, Christie MJ, Connor M (2002) Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. Journal of Physiology (London), 543, 531-540
  25. Marinelli S, Vaughan CW, Schnell SA, Wessendorf MW and Christie MJ (2002). Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. Journal of Neuroscience (in press)
  26. **Moussa CEH, Mitrovic,AD, Vandenberg RJ, **Provis T, **Rae C, **Bubb WA. and **Balcar VJ (2002) Effects of L-glutamate transport inhibition by a conformationally restricted glutamate analogue (2S,1 ' S,2 ' R)-2-(carboxycyclopropyl)glycine (L-CCG III) on metabolism in brain tissue in vitro analysed by NMR spectroscopy, Neurochemical Research, 27, 27-35
  27. *Osborne PB, *Vidovic M, Chieng B, *Hill CE and Christie MJ (2002) Expression of mRNA and functional alpha1-adrenoceptors that supress the GIRK conductance in adult rat locus coeruleus neurons. Brit. J Pharmacol. 135, 226-232
  28. Reyes L, Tinworth KD, Li KM, Yau DF and Waters KA (2002) Observer-blinded comparison of two non-opioid analgesics for postoperative pain in piglets. Pharmacology, Biochemistry and Behavior (in press)
  29. Rƒdiger JJ, Roth M, Bihl MP, Cornelius BC, Johnson M, Ziesche R, Block L (2002) Interaction of C/EBP alpha and the glucocorticoid receptor in vivo and in nontransformed human cells. FASEB Journal, 16, 177-184
  30. Rivory LP, Slaviero KA. and *Clarke SJ (2002) Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response. British Journal of Cancer, 87, 277-280
  31. Roberts LA, Christie MJ, Connor M (2002) Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. British Journal of Pharmacology, 137, 421-428
  32. Roth M, Johnson PRA, Ruediger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL (2002) Interaction between glucocorticoids and beta-2 agonists on bronchial airway smmoth muscle cells through synchronised cellular signalling, The Lancet 360, 1293-1300
  33. Ryan RM and Vandenberg RJ (2002) Distinct conformational states mediate the transport and anion channel properties of the glutamate transporter, EAAT1. Journal of Biological Chemistry (in press 29/2/02)
  34. Shenfield G, Lim E and Allen H (2002) Survey of the use of complementary medicines and therapies in children with asthma. J. Paediatr. Child Health. 38, 252-257
  35. *Spurdle AB, *Goodwin B, *Hodgson E, *Hopper JL, *Chen X, *Purdie DM, *McCredie MRE, *Giles GG, *Chenevix-Trench G, Liddle C (2002) The CYP3A4*1B Polymorphism has no Functional Significance and is not Associated with Risk of Breast or Ovarian Cancer. Pharmacogenetics, 12, 355-366
  36. Stedman C (2002) Herbal Hepatotoxicity. Seminars in Liver Disease, 22, 195-206
  37. Vien J, Duke RK, Mewett KN, Johnston GAR, *Shingai R and **Chebib M (2002) trans-4-Amino-2-methylbut-2-enoic acid (2-MeTACA) and (±)-trans-2-aminomethylcyclopropanecarboxylic acid ((±)-TAMP) can differentiate rat rho-3 from human rho-1 and rho-2 recombinant GABA-C receptors British Journal of Pharmacology, 135, 883-890)
Back to top

Other publications

  1. Duke RK, **Chebib M, Duke CC, Johnston GAR and **Roufogalis BD (2002) Ginkgo biloba - food for the brain, New Zealand Pharmacy, 22(5), 27-33)
  2. Shenfield GM, *Le Couteur DG and Rivory LP (2002) Clinical pharmacology. Medical Journal of Australia. 176(1):9
  3. Shenfield GM (2002) Larking about. Lancet, 359, 2046
  4. Shenfield GM, Morris R (2002) Therapeutic Drug Monitoring. Current Opinion in Anaesthesiology, 15, 687-692
  5. Shenfield GM (2002) Drug interactions with OCs. Australasian Women's Health, 43-47
  6. Shenfield GM (2002) Innocence revisited. Medicine Today, 3, 85-86
  7. *Topliss JG, *Clark AM, *Ernst E., *Hufford C, Johnston GAR , *Rimoldi JM and *Weimann BJ (2002), Natural and synthetic substances related to human health (IUPAC Technical Report) Pure and Applied Chemistry, 74, 1957-1985
Back to top

Patents registered

  • Neurologically-active compounds (**Chebib M, **Hanrahan JR and Johnston GAR, 29 November 2002, International Patent Application No. PCT/AU02/01624)
Back to top

NOTE:
**Member of another department, University of Sydney
*Not a member of the University of Sydney